A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in Copenhagen. “The likelihood of...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2dJM1xr
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 4 January 2018 Source: European Journal of Radiology Author(s): Peiyao Zhang, Jing Wang, Qin Xu, Zhen...
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
Publication date: Available online 18 May 2016 Source: Cellular Signalling Author(s): José M. Muñoz-Félix, Cristina Cuesta, Nuria Perretta...
-
ACS Nano DOI: 10.1021/acsnano.7b02060 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2r2L7mh via...
-
The diffusion and adsorption behaviors of sodium and cesium were investigated in the Callovo-Oxfordian claystones (France) under unsaturated...
-
Abstract Ocean acidification increases the amount of dissolved inorganic carbon (DIC) available in seawater which can benefit photosynthes...
-
Abstract Over the past decades, an increasing need in renewable resources has progressively appeared. This trend concerns not only fossil f...
-
Zeinab Nazeeh Shata, Marwa R Amin, Heba M El-Kady, Mervat W Abu-Nazel Avicenna Journal of Medicine 2017 7(2):54-63 Background: Unlike ot...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου